MENU

ESLA Estrella Immunopharma Forecast, Technical & Fundamental Analysis

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company... Show more

ESLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ESLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ESLA is expected to report earnings to rise 60.00% to -7 cents per share on December 02

Estrella Immunopharma ESLA Stock Earnings Reports
Q3'26
Est.
$-0.08
Q2'26
Beat
by $0.12
Q1'26
Beat
by $0.13
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.05
The last earnings report on September 02 showed earnings per share of -5 cents, beating the estimate of -17 cents. With 1.49K shares outstanding, the current market capitalization sits at 18.76M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
5858 Horton Street
Phone
+1 510 318-9098
Employees
N/A
Web
https://www.estrellabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBK27.110.82
+3.12%
First Internet Bancorp
AFYA12.080.04
+0.33%
Afya Limited
WBD30.95N/A
N/A
Warner Bros Discovery
LAUR38.00-0.16
-0.42%
Laureate Education
RKTO0.69-0.02
-3.32%
Rocket One Inc.

ESLA and Stocks

Correlation & Price change

A.I.dvisor tells us that ESLA and PRLD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and PRLD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
+1.78%
PRLD - ESLA
28%
Poorly correlated
-3.07%
ARMP - ESLA
25%
Poorly correlated
-9.81%
BMEA - ESLA
23%
Poorly correlated
-2.26%
LIMN - ESLA
23%
Poorly correlated
+1.61%
FATE - ESLA
23%
Poorly correlated
-2.95%
More
Estrella Immunopharma (ESLA) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com